TIFFANY BACKINGER: Open Payments
NPI 1942716287 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 24 payments from 14 companies in 2025. Trend: 2023 $611 · 2024 $297 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $72 |
| ABBVIE INC. | 3 | $63 |
| PFIZER INC. | 3 | $51 |
| Gilead Sciences, Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Lilly USA, LLC | 2 | $32 |
| Lundbeck LLC | 1 | $25 |
| ABIOMED | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Philips North America LLC | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, Wegovy, MOUNJARO, NURTEC ODT, REXULTI, Ozempic, JARDIANCE.
Industry payments across OH — which companies pay providers there.
